When was Akonni founded?

Akonni was founded in 2003 and raised its 1st funding round within a year of its incorporation.

Where is Akonni located?

Akonni is headquartered in Frederick, United States. It is registered at Frederick, Maryland.

How many employees does Akonni have?

As of Aug 31, 2026, the latest employee count at Akonni is 16.

Is Akonni a funded company?

Akonni is a funded company, having raised a total of $39.7M across 51 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 2003.

When was the latest funding round of Akonni?

Akonni's latest funding was a $***** Grant (prize money) round on Sep 20, 2021, with participation from 1 investor.

Where does Akonni rank among its competitors?

Akonni ranks 33rd amongst 609 active competitors, of which 126 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Huwel Life, which secured $5.64M in Sep, 2025.

Who are the top competitors of Akonni?

Akonni's top competitors include Adaptive Biotechnologies, MeMed and HaystackAnalytics. Among them, Huwel Life secured the most recent funding round in September, 2025.

Akonni - 2026 Company Profile, Team, Funding & Competitors

Company Details

Molecular diagnostics and sample prep solutions for high-quality nucleic acid purification. The company develops, manufactures, and markets integrated molecular diagnostic systems. They offer solutions for nucleic acid extraction from a wide range of samples, delivering high purity and sensitivity. Their product line includes tips and kits designed to optimize sample prep workflows. They focus on providing cutting-edge solutions for academic and clinical research, enabling breakthroughs in nucleic acid extractions. The company's technology offers higher purity than magnetic beads and greater sensitivity than spin columns. They provide products and services related to molecular diagnostics, sample preparation, DNA extraction, RNA extraction, and nucleic acid purification.

Website: akonni.com
Registered Address: Frederick, Maryland

Key Metrics

Founded Year

2003

Location

Frederick, United States

Stage

Series C

Total Funding

$39.7M in 51 rounds

Latest Funding Round

Grant (prize money), Sep 20, 2021, $*****

Investors

Righton & 6 more

Ranked

33^rd among 609 active competitors

Employee Count

16 as on Aug 31, 2026

Similar Companies

Adaptive Biotechnologies & 765 more

View Akonni's full profile

Akonni is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Akonni Biosystems, Inc. CIN: 161664925 , United States, Active	Dec 26, 999	-	10 (As on Dec 31, 2024)	-

Akonni has raised a total funding of $39.7M over 51 rounds. Its first funding round was on Jul 2003. Its latest funding round was a Grant (prize money) round on Sep 20, 2021 for $*****. 1 investor participated in its latest round. Akonni has 7 institutional investors.

Here is the list of recent funding rounds of Akonni:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 20, 2021	2823751	Grant (prize money)	1340496	1938827	3650862	5320828
Apr 21, 2021	9573803	Grant (prize money)	9017130	5853018	8775840	HHS
Jun 19, 2019	7397924	Series C	3291757	4400234	7848318	9065299

Access funding benchmarks and valuations. Sign up today!

View details of Akonni's funding rounds and investors

Here are the details of Akonni's key team members:

Charles Daitch: CEO of Akonni. They serve on the board of 1 company.

Akonni's Board of Directors

Akonni's board has 19 active members. Michael Murphy, Mark Wood, Michael Farmer, Thomas Higgins, Jon Davis, Jennifer Reynolds, Ron Pion, Tom McMahon, George Rudy, Chuck Parrish, Dr. Myun Han, Charles Daitch, Darrell Chandler, Brian Morra, Mary Pittman, Dr. Jialu Wu, Lawrence Firestone, David Keys and Mary Pitman are independent board members.

Here is the list of Akonni's board of directors:

Name	Type	Representing	Status	Duration
Michael Murphy	Independent board member	-	Current	9y 5m
gfluttv	Independent board member	-	Current	3y 4m
fmikbnb	Independent board member	-	Current	4y 1m
vgc{vj{	Independent board member	-	Current	6y 1m
zunzevw	Independent board member	-	Current	2y 2m
wgdw{te	Independent board member	-	Current	8y 6m
aikenbn	Independent board member	-	Current	1y 4m
u{ttyji	Independent board member	-	Current	3y 6m
vbcnhkj	Independent board member	-	Current	5y 7m
{v{qiin	Independent board member	-	Current	4y 9m
zpqnnuo	Independent board member	-	Current	3y 7m
yxfctwt	Independent board member	-	Current	6y 6m
uhdhrlk	Independent board member	-	Current	9y 3m
badcsda	Independent board member	-	Current	5y 5m
lnjjmdc	Independent board member	-	Current	1y 1m
qvtcazx	Independent board member	-	Current	5y 1m
abqvyna	Independent board member	-	Current	3y 5m
jraebnh	Independent board member	-	Current	2y 9m
sswazvr	Independent board member	-	Current	2y 6m

View details of Akonni's Founder profiles and Board Members

Akonni's employee count trend

Akonni has 16 employees as of Aug 26. Here is Akonni's employee count trend over the years:

Uncover Akonni's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Akonni include Adaptive Biotechnologies, MeMed and HaystackAnalytics. Here is the list of Top 10 competitors of Akonni, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Adaptive Biotechnologies 2009, Seattle (United States), Public	Provider of clinical diagnostics, and drug discovery for immune diseases	$419M	Viking Global Investors, Matrix & 21 others	72/100
2nd	MeMed 2009, Tirat Carmel (Israel), Series D	Provider of machine learning based diagnostic solutions for infectious diseases	$163M	La Maison Partners, Ping An & 23 others	69/100
3rd	HaystackAnalytics 2018, Mumbai (India), Seed	Provider of genomics technology for personalized clinical decisions	$17.3M	STRIVE, Sun Pharma & 33 others	67/100
4th	Nautilus Biotechnology 2016, Seattle (United States), Public	Developer of proteomics platform for drug development	$453M	Vulcan, Bain Capital Life Sciences & 8 others	65/100
5th	Somalogic 1999, Boulder (United States), Acquired	Developer of protein-based assays for life science research	$664M	ProQuest Investments, ICarbonX & 27 others	64/100
6th	Biognosys 2008, Schlieren (Switzerland), Acquired	Provider of proteomics service	$9.13M	Syngenta Group, Zurcher Kantonalbank & 6 others	63/100
7th	PathogenDX 2014, Tucson (United States), Series B	Provider of DNA-based pathogen testing kits	$11.6M	Entourage Effect Capital, Altitude Investment Management ... & 11 others	61/100
8th	Agendia 2003, Irvine (United States), Series F	Provider of genomic diagnostic products for the treatment of cancer	$123M	Athyrium Capital Management, Van Herk Groep ... & 9 others	59/100
9th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
10th	Arzeda 2008, Seattle (United States), Series B	Developer of enzyme design technology to bridge the gap by creating synthetic enzymes	$95.2M	OS Fund, Conti Ventures & 22 others	59/100
33rd	Akonni 2003, Frederick (United States), Series C	Molecular diagnostics and sample prep solutions for high-quality nucleic acid purification	$39.7M	Choosemaryland.org, HHS & 5 others	49/100